1. Home
  2. ITGR vs BHC Comparison

ITGR vs BHC Comparison

Compare ITGR & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITGR
  • BHC
  • Stock Information
  • Founded
  • ITGR 1970
  • BHC N/A
  • Country
  • ITGR United States
  • BHC Canada
  • Employees
  • ITGR N/A
  • BHC N/A
  • Industry
  • ITGR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • BHC Biotechnology: Pharmaceutical Preparations
  • Sector
  • ITGR Health Care
  • BHC Health Care
  • Exchange
  • ITGR Nasdaq
  • BHC Nasdaq
  • Market Cap
  • ITGR 2.4B
  • BHC 2.2B
  • IPO Year
  • ITGR 2000
  • BHC N/A
  • Fundamental
  • Price
  • ITGR $72.09
  • BHC $6.36
  • Analyst Decision
  • ITGR Buy
  • BHC Hold
  • Analyst Count
  • ITGR 8
  • BHC 2
  • Target Price
  • ITGR $92.86
  • BHC $9.00
  • AVG Volume (30 Days)
  • ITGR 994.6K
  • BHC 2.9M
  • Earning Date
  • ITGR 10-23-2025
  • BHC 10-29-2025
  • Dividend Yield
  • ITGR N/A
  • BHC N/A
  • EPS Growth
  • ITGR N/A
  • BHC N/A
  • EPS
  • ITGR 2.42
  • BHC 0.97
  • Revenue
  • ITGR $1,831,074,000.00
  • BHC $10,029,000,000.00
  • Revenue This Year
  • ITGR $9.69
  • BHC $6.81
  • Revenue Next Year
  • ITGR $0.48
  • BHC $4.11
  • P/E Ratio
  • ITGR $29.61
  • BHC $6.46
  • Revenue Growth
  • ITGR 9.54
  • BHC 5.86
  • 52 Week Low
  • ITGR $62.00
  • BHC $4.25
  • 52 Week High
  • ITGR $146.36
  • BHC $8.69
  • Technical
  • Relative Strength Index (RSI)
  • ITGR 43.28
  • BHC 49.50
  • Support Level
  • ITGR $70.88
  • BHC $5.91
  • Resistance Level
  • ITGR $72.62
  • BHC $6.38
  • Average True Range (ATR)
  • ITGR 1.72
  • BHC 0.26
  • MACD
  • ITGR 1.74
  • BHC -0.01
  • Stochastic Oscillator
  • ITGR 88.42
  • BHC 41.04

About ITGR Integer Holdings Corporation

Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.

About BHC Bausch Health Companies Inc.

Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

Share on Social Networks: